Method for optimizing the treatment of chronic myeloid...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/506 (2006.01) A61P 35/02 (2006.01) G01N 33/60 (2006.01)

Patent

CA 2691200

The present invention relates to a method for evaluating patients to help optimizing the treatment of chronic myeloid leukemia (CML) in a human patient population. More specifically, the method comprises the steps of (a) determining the OCT-1 Activity in pre-therapy blood of a warm-blooded animal suffering from CML, and (b) administering a daily dose between about 500 and 1200 mg of Imatinib mesylate to the warm-blooded animal suffering from CML showing an OCT-1 Activity corresponding to Imatinib intracellular concentration below about 6.0 to 10.0 ng/200,000 cells, especially about 8.0 to 8.5 ng/200,000 cells.

La présente invention a pour objet un procédé d'évaluation de patients pour aider à optimiser le traitement de la leucémie chronique myéloïde (LCM) dans une population de patients humains. De manière plus spécifique, le procédé comprend les étapes consistant à (a) déterminer l'activité OCT-1 dans le sang avant le traitement d'un animal à sang chaud souffrant de LCM et (b) administrer une dose quotidienne comprise entre environ 500 et 1200 mg de mésylate d'Imatinib à l'animal à sang chaud souffrant de LCM présentant une activité OCT-1 correspondant à la concentration intracellulaire d'Imatinib inférieure à environ 6,0 à 10,0 ng/200 000 cellules, spécialement environ 8,0 à 8,5 ng/ 200 000 cellules.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for optimizing the treatment of chronic myeloid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for optimizing the treatment of chronic myeloid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for optimizing the treatment of chronic myeloid... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1701680

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.